atovaquone 150 MG/ML Oral Suspension
RxNorm concept 308429, clinical drug (scd). Prescribable name: atovaquone 750 MG in 5 mL Oral Suspension.
- RxCUI
- 308429
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/308429 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
atovaquone 1500 MG per 10 ML Oral Suspension; atovaquone 750 MG per 5 ML Oral Suspension
Related concepts
- atovaquone 150 MG/ML (SCDC, consists of)
- Oral Suspension (DF, has dose form)
- atovaquone 150 MG/ML Oral Suspension [Mepron] (SBD, has tradename)
Linked data
NDCs
- 00121088805
- 00121088818
- 00121088842
- 00121089818
- 00121089842
- 00121095608
- 00121101605
- 00121101618
- 00121101642
- 00121179620
- 00904706425
- 00904706441
- 00904706453
- 00904745925
- 00904745941
- 00904745953
- 10702022321
- 16714090001
- 17856063101
- 17856063102
- 17856863101
- 31722062921
- 42239000108
- 42239000117
- 42239000166
- 50268008611
- 50268008612
- 50268011911
- 50268011912
- 51407064287
- 60687053436
- 60687053440
- 60687053446
- 60687053452
- 60687053478
- 62135052809
- 62135052824
- 62135052845
- 63739020301
- 63739020302
- 63739020303
- 65162069388
- 66689006201
- 66689006218
- 66689006242
- 66993006272
- 68180028201
- 68462042105
- 68462042121
- 68462042169
- 68999052824
- 68999052845
- 69452025287
- 70166048805
- 70166048810
- 70748029901
- 72603024801
- 73141010405
- 73141010442
- 73190009821
And 7 more in the API response.
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 308429 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/308429 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 308429. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.